Motley Fool Money: 4.11.2014

Motley Fool Money: 4.11.2014

The Nasdaq records its worst day in more than two years. eBay and Carl Icahn decide to play nice. And Panera's CEO compares his restaurant to a mosh pit. Our analysts discuss those stories and share three stocks on their radar. Plus, Motley Fool columnist Morgan Housel shares his insights on market volatility, portfolio diversification, and T. Boone Pickens. Learn more about your ad choices. Visit megaphone.fm/adchoices

Avsnitt(2097)

Are SPACs Done?

Are SPACs Done?

What does it say that no private company wants a check for $1.1 billion? (0:21) Bill Mann discusses: - The stock market being surprised that the Fed raised rates by 0.75% (as almost everyone expected...

22 Sep 202223min

YouTube vs. TikTok

YouTube vs. TikTok

Alphabet, parent company of YouTube, deploys a new weapon in its battle with TikTok: cash. (0:25) Maria Gallagher discusses: - YouTube's announcement of a new revenue-sharing model for creators of sh...

21 Sep 202223min

"Make no mistake, this too shall pass."

"Make no mistake, this too shall pass."

Bear markets always come to an end, but they're not necessarily fun while they last. (0:21) Bill Mann discusses: - The market reacting to the Federal Reserve's announcement a day before the Fed actua...

20 Sep 202227min

Pessimism High? Might Be Time To Buy

Pessimism High? Might Be Time To Buy

"The best time to buy is when pessimism is prevalent." (0:21) John Rotonti discusses: - Why the rise in investor pessimism gets him excited to go shopping for investments - What he's watching - A...

19 Sep 202220min

Liz Ann Sonders on Economic Cycles, Stock Prices, and Investing Mistakes

Liz Ann Sonders on Economic Cycles, Stock Prices, and Investing Mistakes

Shorter economic cycles and more frequent recessions doesn't necessarily mean the downturns will be brutal. John Rotonti talked with Liz Ann Sonders, Chief Investment Strategist at Charles Schwab, abo...

18 Sep 202230min

CRISPR, Gene Therapies, and Cure Pricing Conundrums

CRISPR, Gene Therapies, and Cure Pricing Conundrums

Genetically edited humans are already here. Gene editing has massive implications for treating chronic illnesses and even the food we eat. So what does this mean for your investments and, y'know, poss...

17 Sep 202224min

Amazon's Big Bet on the NFL

Amazon's Big Bet on the NFL

Another rough week for the stock market coincides with Amazon's exclusive start to Thursday Night Football. (0:30) Emily Flippen and Ron Gross discuss: - FedEx shares having a historically bad day am...

16 Sep 202239min

Housing Trends w/ Trex CEO Bryan Fairbanks

Housing Trends w/ Trex CEO Bryan Fairbanks

Regulators take a closer look at buy-now, pay-later companies. (0:21) Bill Mann discusses: - The Consumer Financial Protection Bureau announcing plans to oversee BNPL businesses like Affirm Holdings ...

15 Sep 202226min

Populärt inom Business & ekonomi

badfluence
framgangspodden
varvet
rss-jossan-nina
rss-borsens-finest
avanzapodden
uppgang-och-fall
borsmorgon
fill-or-kill
svd-tech-brief
bathina-en-podcast
lastbilspodden
rss-kort-lang-analyspodden-fran-di
rikatillsammans-om-privatekonomi-rikedom-i-livet
kapitalet-en-podd-om-ekonomi
affarsvarlden
loungepodden
rss-dagen-med-di
dynastin
rss-inga-dumma-fragor-om-pengar